Sharper Prostate MRI Scans May Not Mean Better Cancer Detection, Review Finds
Sharper Prostate MRI Scans May Not Mean Better Cancer Detection, Review Finds
Sharper Prostate MRI Scans May Not Mean Better Cancer Detection, Review Finds
Imaging Biomarkers Advance Early ASCVD Detection
Facebook Live: CT of Primary Liver Masses
JACC says AI used solely as a writing tool does not require disclosure. The real question is whether authors take responsibility for the science, verify claims, and stand behind every word. ~70% of journals have AI policies yet only ~1 in 1,000 papers disclosed AI writing aid.
RadNet cites study modeling 18.9% fewer prostate biopsies with AI
AI Reads MRI Scans to Spot Dangerous Prostate Cancer Before Biopsy
CorePrep, a free community-supported radiology qbank, now has 1,200+ board review questions. It’s a promising alternative to expensive test prep, with easy submission. Radiologists can contribute cases to build a high-quality, free resource.
Pixclara—the first FDA-approved FET-PET tracer for glioma—has been administered to its first U.S. patients. Now commercially available, it aids in evaluating suspected recurrence. Gliomas account for ~24,000 new cases annually, representing a significant unmet need.
RSNA 2026 Technical Exhibits to Showcase Innovations in Radiology
Final MARLIN Report on Radiation Incident Reporting Released
ECR 2027 Sees Record-Breaking Abstract Submissions
Guerbet Advances MRI Diagnostics with Innovative Solutions
Optiray® (Ioversol Injection) Demonstrates High Imaging Quality and Safety Profile
O.N. Diagnostics hit with FDA warning letter
CARPL.ai and HOPPR partner on AI foundation models.
Letter to the Editor: AI, regulation, and the radiologist workforce: reorganization without replacement.
UroVision, an AI tool for MR urography, achieved excellent agreement with ImageJ for drainage curve classification (κ=0.86) and renal volume (r=0.99) in children with congenital kidney anomalies, though functional parameter correlations were lower (r=0.57-0.63).
Unenhanced subtraction MRI using 3D-FLAIR at two inversion times yielded higher SNR than enhanced sequences (p<0.001) and excellent agreement for endolymphatic hydrops grading in 202 patients, offering a contrast-free approach.
Specificity for malignant IPMN rose from 66.9% to 89.9% with revised MRI cutoffs (HRS-95), but sensitivity fell from 82.7% to 53.1%; AUC improved significantly (from 0.771 to 0.795–0.808, p=0.046).
In a 20-patient phase II trial, transient flow modulation with rapid-resorbable gelatin microspheres reduced yttrium-90 (Y-90) deposition in non-tumorous liver by a median 35.8% (IQR 20.2-66.7) and preserved function on MRI at 6 months (p<0.001).
MRI segmentation-derived abscess volume improved prediction of ICU admission (AUC 0.841 [95%CI 0.78-0.90] vs. 0.816 for diameter), and lower sphericity independently predicted prolonged stay.
Amylo-Detect, a machine learning model using 50 EHR variables, predicted cardiac amyloidosis on bone scintigraphy with an AUC of 0.91 in external validation, outperforming clinical routine and detecting 29% of missed cases.
Real-world AI for prostate MRI in the NHS depends more on governance, human-in-the-loop safety, and workflow integration than on algorithm validation alone. Clinical efficacy requires quality application, not just high accuracy.
Combined ethanol ablation plus radiofrequency ablation (RFA) vs RFA alone was associated with a 4.17-fold increase in the odds of achieving ≥85% volume reduction at 12 months in predominantly cystic thyroid nodules (adjusted OR 4.17, 95% CI 1.61–11.70, P=.004).
Combined Portal and Hepatic Vein Embolization to Enhance the Future Liver Remnant in Pediatric Hepatoblastoma.
In emergency uterine artery embolization for postpartum hemorrhage, NBCA achieved hemostasis in all 7 initial and 8 salvage cases after GS failure, with final success 96.1%. Among 46 with uterine preservation, subsequent pregnancy rates were 19.4% after GS alone vs 20.0% after N…
Transformer-based 2.5D model restored 2×2‑accelerated vessel wall imaging to match twofold GRAPPA quality: peak SNR ↑ >7 dB, SSIM ↑ 0.19. Prospective multi‑center testing showed significant SNR & CNR gains, enabling whole‑brain VWI under 6 min with standard coils.